Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer.
about
Recent updates of precision therapy for gastric cancer: Towards optimal tailored managementEpstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune ResponseImmunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigationsPD-1 and its ligands are important immune checkpoints in cancerPrognostic significance of PD-L1 in solid tumor: An updated meta-analysis.Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy.The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy.Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.The expression status and prognostic significance of programmed cell death 1 ligand 1 in gastrointestinal tract cancer: a systematic review and meta-analysisTumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer.The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma.Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysisTumor-infiltrating macrophages express interleukin-25 and predict a favorable prognosis in patients with gastric cancer after radical resectionImmune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma.Tumor CTLA-4 overexpression predicts poor survival in patients with nasopharyngeal carcinoma.Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability.Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis.PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer.PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidenceConcordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer.Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1+ immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications.Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer.Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy.Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysisCombined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers.Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis.Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma.EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release.Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis.CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases.Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases.Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer.Predictive relevance of PD-L1 expression with pre-existing TILs in gastric cancer.Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection.
P2860
Q26746246-599D91F3-0C80-495E-B544-27E6D5BAD534Q26751029-0D03D327-1B7F-4CF7-B5D1-801F7756A778Q26781038-B068C780-238C-4767-8C9E-10600F2E2EBEQ28069485-82527DEE-1041-4CA9-9FE6-E6F1D4132BDDQ33644049-CFF8E77E-DDF5-4A1A-946A-4A4CFEAEAB98Q33714143-B709558E-67D1-48C1-BDDA-40471B8F99D5Q33888982-B8B40E27-A67C-4432-8977-2379C5E2B3DDQ35604318-37F028AB-E4CE-4311-8D23-D325A83E31DAQ36072022-123C731F-E239-41B7-8737-E7EE6177739DQ36116591-3E5C1889-B716-4FD8-9272-4703FC7AB245Q36195996-D8E0702F-AD1E-40F3-9252-D04E7417ABABQ36205148-B8676BC4-A23D-4988-9AB2-1908E94804C3Q36591970-67860C07-2609-4843-A87B-30769CE0A598Q36891533-CB6BA2B1-7497-481D-AA01-B6D877367B57Q36998164-FB38F909-8944-4F59-A554-3BB927215BFBQ37012537-281D6315-BFD5-4411-BB06-D7E588FB547EQ37022378-6BF0E4A1-1438-4C9F-9B7B-3425B3B9195BQ37706604-9D87BA32-AF57-4EE6-9B2F-6DBCCC144E27Q38369260-93409514-030E-4D07-B5EA-612A8B9D6C05Q38630412-7356F66B-2F11-4C74-88F2-C27A9D67DE36Q38642012-9E0E94F3-3D59-4590-B63B-C2728B77160BQ38649562-E5C485A0-5416-40E8-81EF-FAE14CADDAB6Q39308620-7F4C48FB-0F4E-4C1C-9D34-53214E404686Q40416586-652A4BA0-BE29-43B4-9283-343EF52D2C80Q40581214-70BC6D4A-4EEC-4B4B-BDBC-681852F9E9E0Q40869208-4D6982B0-3A34-419B-9F9F-BB2358DCA847Q41110505-848F13BB-64F2-40A7-AE08-4483FFBF7937Q41149149-2D0EF8D9-6E5A-49A8-B370-F576266109E5Q41445876-7675DE79-F20E-46CD-8FD9-A6DE8F10D779Q41708934-A9A19138-3CB4-4F61-9442-FA7A3F078849Q41763532-E594A58F-F6CA-4FB5-B8FA-DE5406382CC8Q41967898-557B1B57-5824-4407-A3CB-E1CAB8C2E07DQ42030787-6C24D61E-8D5C-43D7-8F3E-7ED656F31101Q42682646-544CB774-0246-4764-8AD6-F97C8E173BEDQ42683596-EF50CBBA-3528-403D-9A64-B427DC54D16EQ42705635-0D83926B-91FC-4331-9C0E-D477E7363AC4Q45325629-D5A2FD9E-9CE5-4EED-A4A5-B5991F0B36A3Q46022555-A94BA46D-10C6-434E-BE0B-37EC3362400DQ47137632-17836C70-E223-4868-BCB2-B04DF8373F18Q47143363-44F1BB2F-4951-4427-B7F0-D67F81C84C56
P2860
Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Prognostic implications of imm ...... environment in gastric cancer.
@en
Prognostic implications of imm ...... environment in gastric cancer.
@nl
type
label
Prognostic implications of imm ...... environment in gastric cancer.
@en
Prognostic implications of imm ...... environment in gastric cancer.
@nl
prefLabel
Prognostic implications of imm ...... environment in gastric cancer.
@en
Prognostic implications of imm ...... environment in gastric cancer.
@nl
P2093
P2860
P1433
P1476
Prognostic implications of imm ...... environment in gastric cancer.
@en
P2093
Do Joong Park
Hye Seung Lee
Hyun Chang
Hyung-Ho Kim
Jee Hyun Kim
Jeong-Ok Lee
Jin Won Kim
Jong Seok Lee
Keun-Wook Lee
Kyung Han Nam
P2860
P2888
P356
10.1007/S10120-014-0440-5
P577
2014-11-26T00:00:00Z